Search

everythinglearnresearchcommunity

for

Search:↓

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

SH-MSCs gel reduced IL-6 and increased TGF-β, suggesting it could treat alopecia.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Computational tools identified 29 drugs that could potentially target 19 genes involved in chemotherapy-induced hair loss, which could lead to more effective treatments.

Rats can develop an immune response to prion protein peptides, but it may cause severe skin issues in older rats.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Hair follicles help attract immune cells to the skin during stress.

Scalp cooling is an effective and safe way to prevent hair loss from chemotherapy, with manageable side effects and low risk of scalp cancer.

Some patients using cold caps to prevent hair loss from chemotherapy got mild scalp injuries similar to frostbite.

Xiaoaiping reduces chemotherapy side effects and improves quality of life for breast cancer patients.

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

Oncologists should better understand the unique impact of hair loss on Black breast cancer patients to offer more compassionate care.

Scientists created complete hair-like structures by growing mouse skin cells together in a special gel.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

The CNC® prosthetic system improved body image in breast cancer patients with hair loss from chemotherapy but did not significantly change their psychological wellbeing.

Most women undergoing chemotherapy experience hair loss, and many cope by using wigs or bonnets.

Scientists used stem cells to create a model of the skin disease Epidermolysis Bullosa simplex, which helped them understand its molecular mechanisms and could aid in finding treatments.

Scalp cooling reduces chemotherapy-induced hair loss without increasing risk of skin metastases.

Hair loss affects self-esteem and quality of life; treatments can help.